Possibia

740649

Last Update Posted: 2009-03-31

Recruiting has ended

Males

accepted

20 Years-45 Years

74 Estimated Participants

No Expanded Access

Interventional Study

Accepts healthy volunteers

Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of HSD-016

This is a single ascending dose study of HSD-016 to provide the initial assessment of the safety, tolerability, how the drug is absorbed and eliminated, and it's effect on the body in Japanese male subjects.

Eligibility

Relevant conditions:

Healthy Subjects

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Data sourced from ClinicalTrials.gov